JOHN GLENN - 20 Jun 2023 Form 4 Insider Report for IRADIMED CORP (IRMD)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ John Glenn
Issuer symbol
IRMD
Transactions as of
20 Jun 2023
Transactions value $
-$67,607
Form type
4
Filing time
22 Jun 2023, 16:30:13 UTC
Previous filing
16 Dec 2022
Next filing
11 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IRMD Common Stock Options Exercise +5.8K +231.8% 8.3K 20 Jun 2023 Direct F1
transaction IRMD Common Stock Tax liability -$67.6K -1.41K -17.02% $47.88 6.88K 20 Jun 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IRMD Restricted Stock Units Options Exercise $0 -5.8K -25% $0.00 17.4K 20 Jun 2023 Common Stock 5.8K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert into common stock on a one-for-one basis.
F2 On June 20, 2022, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on June 20, 2023. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.